Perlecan and tumor angiogenesis.

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Perlecan and tumor angiogenesis. / Jiang, Xinnong; Couchman, John R.

In: Journal of Histochemistry and Cytochemistry, Vol. 51, No. 11, 2003, p. 1393-410.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Jiang, X & Couchman, JR 2003, 'Perlecan and tumor angiogenesis.', Journal of Histochemistry and Cytochemistry, vol. 51, no. 11, pp. 1393-410.

APA

Jiang, X., & Couchman, J. R. (2003). Perlecan and tumor angiogenesis. Journal of Histochemistry and Cytochemistry, 51(11), 1393-410.

Vancouver

Jiang X, Couchman JR. Perlecan and tumor angiogenesis. Journal of Histochemistry and Cytochemistry. 2003;51(11):1393-410.

Author

Jiang, Xinnong ; Couchman, John R. / Perlecan and tumor angiogenesis. In: Journal of Histochemistry and Cytochemistry. 2003 ; Vol. 51, No. 11. pp. 1393-410.

Bibtex

@article{edf0c7f0596211dd8d9f000ea68e967b,
title = "Perlecan and tumor angiogenesis.",
abstract = "Perlecan is a major heparan sulfate proteoglycan (HSPG) of basement membranes (BMs) and connective tissues. The core protein of perlecan is divided into five domains based on sequence homology to other known proteins. Commonly, the N-terminal domain I of mammalian perlecan is substituted with three HS chains that can bind a number of matrix molecules, cytokines, and growth factors. Perlecan is essential for metazoan life, as shown by genetic manipulations of nematodes, insects, and mice. There are also known human mutations that can be lethal. In vertebrates, new functions of perlecan emerged with the acquisition of a closed vascular system and skeletal connective tissues. Many of perlecan's functions may be related to the binding and presentation of growth factors to high-affinity tyrosine kinase (TK) receptors. Data are accumulating, as discussed here, that similar growth factor-mediated processes may have unwanted promoting effects on tumor cell proliferation and tumor angiogenesis. Understanding of these attributes at the molecular level may offer opportunities for therapeutic intervention.",
author = "Xinnong Jiang and Couchman, {John R}",
note = "Keywords: Alternative Splicing; Animals; Extracellular Matrix; Fibroblast Growth Factor 2; Heparan Sulfate Proteoglycans; Humans; Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A",
year = "2003",
language = "English",
volume = "51",
pages = "1393--410",
journal = "Journal of Histochemistry and Cytochemistry",
issn = "0022-1554",
publisher = "SAGE Publications",
number = "11",

}

RIS

TY - JOUR

T1 - Perlecan and tumor angiogenesis.

AU - Jiang, Xinnong

AU - Couchman, John R

N1 - Keywords: Alternative Splicing; Animals; Extracellular Matrix; Fibroblast Growth Factor 2; Heparan Sulfate Proteoglycans; Humans; Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor A

PY - 2003

Y1 - 2003

N2 - Perlecan is a major heparan sulfate proteoglycan (HSPG) of basement membranes (BMs) and connective tissues. The core protein of perlecan is divided into five domains based on sequence homology to other known proteins. Commonly, the N-terminal domain I of mammalian perlecan is substituted with three HS chains that can bind a number of matrix molecules, cytokines, and growth factors. Perlecan is essential for metazoan life, as shown by genetic manipulations of nematodes, insects, and mice. There are also known human mutations that can be lethal. In vertebrates, new functions of perlecan emerged with the acquisition of a closed vascular system and skeletal connective tissues. Many of perlecan's functions may be related to the binding and presentation of growth factors to high-affinity tyrosine kinase (TK) receptors. Data are accumulating, as discussed here, that similar growth factor-mediated processes may have unwanted promoting effects on tumor cell proliferation and tumor angiogenesis. Understanding of these attributes at the molecular level may offer opportunities for therapeutic intervention.

AB - Perlecan is a major heparan sulfate proteoglycan (HSPG) of basement membranes (BMs) and connective tissues. The core protein of perlecan is divided into five domains based on sequence homology to other known proteins. Commonly, the N-terminal domain I of mammalian perlecan is substituted with three HS chains that can bind a number of matrix molecules, cytokines, and growth factors. Perlecan is essential for metazoan life, as shown by genetic manipulations of nematodes, insects, and mice. There are also known human mutations that can be lethal. In vertebrates, new functions of perlecan emerged with the acquisition of a closed vascular system and skeletal connective tissues. Many of perlecan's functions may be related to the binding and presentation of growth factors to high-affinity tyrosine kinase (TK) receptors. Data are accumulating, as discussed here, that similar growth factor-mediated processes may have unwanted promoting effects on tumor cell proliferation and tumor angiogenesis. Understanding of these attributes at the molecular level may offer opportunities for therapeutic intervention.

M3 - Journal article

C2 - 14566013

VL - 51

SP - 1393

EP - 1410

JO - Journal of Histochemistry and Cytochemistry

JF - Journal of Histochemistry and Cytochemistry

SN - 0022-1554

IS - 11

ER -

ID: 5161012